Pacira BioSciences Inc

NASDAQ: PCRX
$25.90
-$0.91 (-3.4%)
Closing price April 24, 2024
Pacira BioSciences Inc specializes in creating non-opioid pain management and regenerative health solutions. Their product lineup includes EXPAREL, a pain relief injectable, ZILRETTA, an extended-release injection for managing osteoarthritis pain, and the iovera system, a device offering temporary pain relief through cold therapy. The company, rooted in innovation for safer pain management, also collaborates on NOCITA, another pain relief injectable. Founded in 2006 and based in Tampa, Florida, Pacira is committed to reducing reliance on opioids in healthcare.
Here are three biotech companies that not only have data that could prove to be huge, but their shares have been absolutely hammered over the last year, offering aggressive accounts the best entry...
Thursday’s top analyst upgrades, downgrades and initiations include Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC and Pure Storage.
These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.
A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political chatter.
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
The include top analyst upgrades, downgrades and initiations on Friday morning Exxon Mobil, International Paper, J.C. Penney, Lululemon and Ulta Beauty.
The three biotech stocks featured here are rated Outperform at Wedbush and have at least 100% potential upside to the posted price targets.
A new report from Wedbush focuses on upcoming catalysts for biotech stocks in the firm's coverage universe. These four have monster potential upside to the posted price targets.
Two recent Wedbush research reports focus is on health care companies that not only have data that could prove to be huge, but that have both been absolutely hammered over the past year.
Pacira Pharmaceuticals announced that it achieved an amicable resolution with the FDA for a lawsuit filed earlier this year that effectively lifts the restriction on its Exparel.
Source: ThinkstockOctober 7, 2015: Here are four stocks trading with heavy volume among 28 equities making new 52-week lows today.GoPro Inc. (NASDAQ: GPRO) dropped more than 10% on Wednesday to post...
Source: ThinkstockIn what was yet another very volatile week for the markets, insider selling and insider buying has been active. We have evaluated some of the top insider selling transactions this...
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Friday, June 27, 2014. They include Alcoa, Cigna, Intel, Molina Healthcare, Teva Pharmaceutical and...
Source: ThinkstockActive traders and more active investors looking for news lists of stocks to buy or other investing ideas often look at stocks which are very active in trading volume. Some are up...
Index changes are generally speaking a fairly routine event.  They can also create underlying moves in the companies added and deleted from them as money management firms often buy and sell shares,...